title: N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02.
abstract: BACKGROUND
  The aim of this study was to determine the incidence of isolated nodal failure in patients with N2/3 disease who achieved a complete clinical and radiological response (CR) at 12 weeks postchemoradiation, when no planned neck dissection was performed.
  
  
  METHODS
  We analyzed the nodal response and subsequent neck control of 102 patients with initial N2/3 disease treated on the Trans Tasman Radiation Oncology Group 98.02 study.
  
  
  RESULTS
  With a median 4.3 years follow-up, the patterns of first failure in the CR patients were local 4%, local and nodal 2%, distant 28%, and locoregional plus distant (within 1 month) 6%. There were no patients who had only neck failure.
  
  
  CONCLUSIONS
  Patients in this trial with N2/3 disease who obtained a clinical and radiological complete response to chemoradiation had a zero incidence of isolated neck failure without a planned neck dissection. The continued use of planned neck dissections in this patient subset cannot be justified.
authors.affiliation: Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. june.corry@petermac.org
authors.forename: June
authors.initials: J
authors.lastname: Corry
authors.forename: Lester
authors.initials: L
authors.lastname: Peters
authors.forename: Richard
authors.initials: R
authors.lastname: Fisher
authors.forename: Andrew
authors.initials: A
authors.lastname: Macann
authors.forename: Michael
authors.initials: M
authors.lastname: Jackson
authors.forename: Bev
authors.initials: B
authors.lastname: McClure
authors.forename: Danny
authors.initials: D
authors.lastname: Rischin
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D037981:Neck Dissection; D018365:Neoplasm, Residual; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents